Skip to content

Clinical trials

Active, not recruiting Carcinoma, Ovarian Epithelial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Active, not recruiting Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20182
20202
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
23andMe, Inc.1
CanariaBio Inc.1
Imunon1
Klus Pharma Inc.1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Theratechnologies1
University Health Network, Toronto1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial9
Fallopian Tube Neoplasms5
Melanoma3
Ovarian Neoplasms3
Small Cell Lung Carcinoma3
Triple Negative Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Endometrial Neoplasms2
Neoplasms2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.